ZA869B - 1,3-disubstituted tetrahydropyridines - Google Patents

1,3-disubstituted tetrahydropyridines

Info

Publication number
ZA869B
ZA869B ZA869A ZA869A ZA869B ZA 869 B ZA869 B ZA 869B ZA 869 A ZA869 A ZA 869A ZA 869 A ZA869 A ZA 869A ZA 869 B ZA869 B ZA 869B
Authority
ZA
South Africa
Prior art keywords
tetrahydropyridines
disubstituted
disubstituted tetrahydropyridines
Prior art date
Application number
ZA869A
Other languages
English (en)
Inventor
Wolfgang Froestl
Angelo Storni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA869B publication Critical patent/ZA869B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/35—Nc in input of data, input till input file format
    • G05B2219/35287—Verify, check program by drawing, display part, testpiece

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA869A 1985-01-03 1986-01-02 1,3-disubstituted tetrahydropyridines ZA869B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1385 1985-01-03

Publications (1)

Publication Number Publication Date
ZA869B true ZA869B (en) 1986-08-27

Family

ID=4177425

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA869A ZA869B (en) 1985-01-03 1986-01-02 1,3-disubstituted tetrahydropyridines
ZA8610A ZA8610B (en) 1985-01-03 1986-01-02 1,3,4-trisubstituted azacycloalkanes and azacycloalkenes

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA8610A ZA8610B (en) 1985-01-03 1986-01-02 1,3,4-trisubstituted azacycloalkanes and azacycloalkenes

Country Status (12)

Country Link
EP (1) EP0187619A3 (fr)
JP (2) JPS61161279A (fr)
KR (1) KR870006036A (fr)
AU (1) AU5178786A (fr)
DD (1) DD251131A5 (fr)
DK (1) DK886A (fr)
FI (1) FI855182L (fr)
GR (1) GR860003B (fr)
HU (1) HUT39442A (fr)
NO (1) NO860008L (fr)
PT (1) PT81781B (fr)
ZA (2) ZA869B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907974A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Indolderivate
US5428043A (en) * 1990-02-08 1995-06-27 Pfizer Inc. Tricyclic-cyclic amines as novel cholinesterase inhibitors
TW197442B (fr) * 1990-02-08 1993-01-01 Pfizer
KR100457857B1 (ko) * 2002-05-23 2004-11-18 (주) 비엔씨바이오팜 2-[2-(3-인돌릴)에틸아미노]피리딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
BRPI0519585A2 (pt) * 2004-12-20 2009-02-25 Hoffmann La Roche compostos de fàrmula i; processo para a fabricaÇço de compostos de fàrmula i; composiÇÕes farmacÊuticas; mÉtodo para o tratamento e/ou profilaxia de doenÇas que estço associadas com a dpp-iv e usos destes compostos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075986A (en) * 1958-01-09 1963-01-29 Rhone Poulenc Sa (1-piperdidylalkyl) derivatives of 3-indole
US3183235A (en) * 1961-06-27 1965-05-11 Sterling Drug Inc 1-[3-, 2-, and 1-indolyl-lower-alkanoyl] piperidines
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3821387A (en) * 1965-10-23 1974-06-28 Robins Co Inc A H The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
DE3233553A1 (de) * 1982-09-10 1984-03-15 Merck Patent Gmbh, 6100 Darmstadt Pyrrolderivate
DE3342632A1 (de) * 1983-11-25 1985-06-05 Merck Patent Gmbh, 6100 Darmstadt Indolderivate

Also Published As

Publication number Publication date
DK886A (da) 1986-07-04
PT81781B (de) 1987-11-05
DD251131A5 (de) 1987-11-04
KR870006036A (ko) 1987-07-08
EP0187619A2 (fr) 1986-07-16
PT81781A (de) 1986-02-01
DK886D0 (da) 1986-01-02
HUT39442A (en) 1986-09-29
FI855182A7 (fi) 1986-07-04
EP0187619A3 (fr) 1987-08-26
AU5178786A (en) 1986-07-17
ZA8610B (en) 1986-08-27
JPS61161279A (ja) 1986-07-21
FI855182L (fi) 1986-07-04
NO860008L (no) 1986-07-04
JPS61161258A (ja) 1986-07-21
GR860003B (en) 1986-04-25
FI855182A0 (fi) 1985-12-30

Similar Documents

Publication Publication Date Title
CS521486A2 (en) Zpusob vyroby substituovanych androsta 1,4 dien 3,17 dionu
ZA87327B (en) 1,4-dihydropyridines
EP0202580A3 (en) 3,4-dihydrobenzopyran derivatives
AU591651B2 (en) 1,4-dihydropyridines
GR861884B (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4,-triazoles
CS331686A2 (en) Zpusob vyroby novych pyridylmethylthiothieno (2,3 d) imidazolovych derivatu
CS468885A1 (en) Sposob pripravy 4 substituovanych 2,2,6,6 tetrametylpiperidin n oxylov
GB2198133B (en) 4,4-dialkyl-2-azetidinones
CS26886A2 (en) Zpusob vyroby 12 aminopyridazino (4,
GB2167745B (en) 1,4-dihydropyridines
ZA8610B (en) 1,3,4-trisubstituted azacycloalkanes and azacycloalkenes
EP0200683A3 (en) 2-û1-hydroxy-2,2,6,6-tetraalkyl-piperidin-4-yloxy¨-dibenzodioxaphosphepines and -dibenzodioxaphosphocines
GB2176183B (en) 2,4-dichloro-5-nitro-thiazole
GB8530178D0 (en) 1,4-dihydropyridine derivatives
ZA872561B (en) 3,3-disubstituted indolines
IE852976L (en) 1,4-dihydropyridines
IE853094L (en) 1,4-dihydropyridines
IE853097L (en) 1,4-dihydropyridines
IE841888L (en) 1,4-dihydropyridines
ZA892823B (en) 1,3-disubstituted pyrrolidines
IE851773L (en) 1,3-propylidenediphosphonates
CS272185A1 (en) Zpusob ziskavani 2,2,6,6 tetrametyl 4 oxipiperidinu
IE852253L (en) 1,2-oxazoles
CS559885A1 (en) Sposob vyroby 1,5 metano 3,7 dinitrozo 1,3,5,7 tetraazacyklooktanu
CS403087A2 (en) Zpusob vyroby novych 1,2 disubstituovanych derivatu ergolinu